Cargando…
New and emerging treatments for estrogen receptor-positive breast cancer: focus on everolimus
Management of patients with metastatic hormone receptor-positive breast cancer poses a challenge due to the inevitable development of endocrine resistance. Hormone resistance is associated with a complex interaction of the estrogen receptor with growth factors, transmembrane receptors, and intracell...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549674/ https://www.ncbi.nlm.nih.gov/pubmed/23345981 http://dx.doi.org/10.2147/TCRM.S30349 |